BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37556531)

  • 1. Structural basis of histone H2A lysine 119 deubiquitination by Polycomb repressive deubiquitinase BAP1/ASXL1.
    Thomas JF; Valencia-Sánchez MI; Tamburri S; Gloor SL; Rustichelli S; Godínez-López V; De Ioannes P; Lee R; Abini-Agbomson S; Gretarsson K; Burg JM; Hickman AR; Sun L; Gopinath S; Taylor HF; Sun ZW; Ezell RJ; Vaidya A; Meiners MJ; Cheek MA; Rice WJ; Svetlov V; Nudler E; Lu C; Keogh MC; Pasini D; Armache KJ
    Sci Adv; 2023 Aug; 9(32):eadg9832. PubMed ID: 37556531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of histone H2A lysine 119 deubiquitination by Polycomb Repressive Deubiquitinase BAP1/ASXL1.
    Thomas JF; Valencia-Sánchez MI; Tamburri S; Gloor SL; Rustichelli S; Godínez-López V; De Ioannes P; Lee R; Abini-Agbomson S; Gretarsson K; Burg JM; Hickman AR; Sun L; Gopinath S; Taylor H; Meiners MJ; Cheek MA; Rice W; Nudler E; Lu C; Keogh MC; Pasini D; Armache KJ
    bioRxiv; 2023 Feb; ():. PubMed ID: 36865140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basis of the H2AK119 specificity of the Polycomb repressive deubiquitinase.
    Ge W; Yu C; Li J; Yu Z; Li X; Zhang Y; Liu CP; Li Y; Tian C; Zhang X; Li G; Zhu B; Xu RM
    Nature; 2023 Apr; 616(7955):176-182. PubMed ID: 36991118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB.
    Scheuermann JC; de Ayala Alonso AG; Oktaba K; Ly-Hartig N; McGinty RK; Fraterman S; Wilm M; Muir TW; Müller J
    Nature; 2010 May; 465(7295):243-7. PubMed ID: 20436459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Regulation of the Polycomb Repressive-Deubiquitinase.
    Reddington CJ; Fellner M; Burgess AE; Mace PD
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer.
    Daou S; Hammond-Martel I; Mashtalir N; Barbour H; Gagnon J; Iannantuono NV; Nkwe NS; Motorina A; Pak H; Yu H; Wurtele H; Milot E; Mallette FA; Carbone M; Affar el B
    J Biol Chem; 2015 Nov; 290(48):28643-63. PubMed ID: 26416890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAP1/ASXL1 recruitment and activation for H2A deubiquitination.
    Sahtoe DD; van Dijk WJ; Ekkebus R; Ovaa H; Sixma TK
    Nat Commun; 2016 Jan; 7():10292. PubMed ID: 26739236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of BAP1 function leads to EZH2-dependent transformation.
    LaFave LM; Béguelin W; Koche R; Teater M; Spitzer B; Chramiec A; Papalexi E; Keller MD; Hricik T; Konstantinoff K; Micol JB; Durham B; Knutson SK; Campbell JE; Blum G; Shi X; Doud EH; Krivtsov AV; Chung YR; Khodos I; de Stanchina E; Ouerfelli O; Adusumilli PS; Thomas PM; Kelleher NL; Luo M; Keilhack H; Abdel-Wahab O; Melnick A; Armstrong SA; Levine RL
    Nat Med; 2015 Nov; 21(11):1344-9. PubMed ID: 26437366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PR-DUB maintains the expression of critical genes through FOXK1/2- and ASXL1/2/3-dependent recruitment to chromatin and H2AK119ub1 deubiquitination.
    Kolovos P; Nishimura K; Sankar A; Sidoli S; Cloos PA; Helin K; Christensen J
    Genome Res; 2020 Aug; 30(8):1119-1130. PubMed ID: 32747411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone H2A deubiquitinases in the transcriptional programs of development and hematopoiesis: a consolidated analysis.
    Wang H; Langlais D; Nijnik A
    Int J Biochem Cell Biol; 2023 Apr; 157():106384. PubMed ID: 36738766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bidentate Polycomb Repressive-Deubiquitinase complex is required for efficient activity on nucleosomes.
    Foglizzo M; Middleton AJ; Burgess AE; Crowther JM; Dobson RCJ; Murphy JM; Day CL; Mace PD
    Nat Commun; 2018 Sep; 9(1):3932. PubMed ID: 30258054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing hyperactivated BAP1 attenuates mutant ASXL1-driven myeloid malignancies in human haematopoietic cells.
    Bai J; Chen Z; Chen C; Zhang M; Zhang Y; Song J; Yuan J; Jiang X; Xing W; Yang J; Bai J; Zhou Y
    Cancer Lett; 2021 Oct; 519():78-90. PubMed ID: 34186160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAP1 complex promotes transcription by opposing PRC1-mediated H2A ubiquitylation.
    Campagne A; Lee MK; Zielinski D; Michaud A; Le Corre S; Dingli F; Chen H; Shahidian LZ; Vassilev I; Servant N; Loew D; Pasmant E; Postel-Vinay S; Wassef M; Margueron R
    Nat Commun; 2019 Jan; 10(1):348. PubMed ID: 30664650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular mechanisms by which the mutant ASXL1/BAP1 complex aggravates myeloid leukemia].
    Asada S
    Rinsho Ketsueki; 2020; 61(4):392-405. PubMed ID: 32378586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Basis for the Activation of the Deubiquitinase Calypso by the Polycomb Protein ASX.
    De I; Chittock EC; Grötsch H; Miller TCR; McCarthy AA; Müller CW
    Structure; 2019 Mar; 27(3):528-536.e4. PubMed ID: 30639226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-derived neomorphic mutations in ASXL1 impairs the BAP1-ASXL1-FOXK1/K2 transcription network.
    Xia YK; Zeng YR; Zhang ML; Liu P; Liu F; Zhang H; He CX; Sun YP; Zhang JY; Zhang C; Song L; Ding C; Tang YJ; Yang Z; Yang C; Wang P; Guan KL; Xiong Y; Ye D
    Protein Cell; 2021 Jul; 12(7):557-577. PubMed ID: 32683582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of B Lymphocyte Development by Histone H2A Deubiquitinase BAP1.
    Lin YH; Liang Y; Wang H; Tung LT; Förster M; Subramani PG; Di Noia JM; Clare S; Langlais D; Nijnik A
    Front Immunol; 2021; 12():626418. PubMed ID: 33912157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex.
    Balasubramani A; Larjo A; Bassein JA; Chang X; Hastie RB; Togher SM; Lähdesmäki H; Rao A
    Nat Commun; 2015 Jun; 6():7307. PubMed ID: 26095772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1.
    Daou S; Barbour H; Ahmed O; Masclef L; Baril C; Sen Nkwe N; Tchelougou D; Uriarte M; Bonneil E; Ceccarelli D; Mashtalir N; Tanji M; Masson JY; Thibault P; Sicheri F; Yang H; Carbone M; Therrien M; Affar EB
    Nat Commun; 2018 Oct; 9(1):4385. PubMed ID: 30349006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PR-DUB preserves Polycomb repression by preventing excessive accumulation of H2Aub1, an antagonist of chromatin compaction.
    Bonnet J; Boichenko I; Kalb R; Le Jeune M; Maltseva S; Pieropan M; Finkl K; Fierz B; Müller J
    Genes Dev; 2022 Oct; 36(19-20):1046-1061. PubMed ID: 36357125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.